The partnership between the University of Oxford and AstraZeneca is a leading candidate to develop a potential vaccine for COVID-19. If this proves successful, it will be undoubtedly unprecedented. However, the next big question is who can mass produce a vaccine that is both affordable and at such a scale?
Who can produce mass vaccines?
- +61 2 9071 0124
- IA@indiaavenue.com.au
- India Avenue Investment Management Pty. Ltd. AFSL 478233 | ABN: 38 604 095 954 Level 4, 261 George Street, Sydney NSW 2000, Australia.
Quick Links
Subscribe
Get our monthly research and updates on our offerings that bring you valuable insights, opinion, and education.
© 2025 India Avenue Investment Management Australia Pty. Ltd. . All rights reserved.
Design and Developed by Aniktantra